Agios Pharmaceuticals, Inc.
AGIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $674 | -$352 | -$232 | -$357 |
| Dep. & Amort. | $6 | $7 | $9 | $9 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $43 | $45 | $49 | $54 |
| Change in WC | -$20 | -$19 | -$16 | -$37 |
| Other Non-Cash | -$1,092 | $24 | -$119 | -$77 |
| Operating Cash Flow | -$390 | -$296 | -$309 | -$407 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$2 | -$1 | -$5 | -$6 |
| Net Acquisitions | $0 | $0 | $133 | $0 |
| Inv. Purchases | -$1,542 | -$418 | -$1,031 | -$1,378 |
| Inv. Sales/Matur. | $818 | $675 | $1,146 | $830 |
| Other Inv. Act. | $1,089 | -$16 | $0 | $1,803 |
| Investing Cash Flow | $363 | $240 | $243 | $1,249 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | -$0 | -$1 |
| Stock Issued | $14 | $5 | $3 | $0 |
| Stock Repurch. | $0 | $0 | $0 | -$802 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $37 |
| Financing Cash Flow | $14 | $5 | $2 | -$766 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$12 | -$51 | -$64 | $76 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $88 | $139 | $203 | $127 |
| End Cash | $76 | $88 | $139 | $203 |
| Free Cash Flow | -$392 | -$297 | -$314 | -$413 |